¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ -7hU1j~I  
hekAics6S  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© pNCk~OM  
_hK7hvM>  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ) ^!oM  
e*:[#LJ]C  
1.Co-stimulators (or co-stimulating molecules) 5d <-y2!M  
t-3wjS1v  
2.NK-kB t?  yMuK  
&7XB $  
3.Immunoglobulin superfamily (<=qW_iW  
"u3  
4.antigen-presenting cell (APC) p$0;~1vH  
VABrw t  
5.death domain N|WnUlf]:  
Yono8M;9*  
6.CCR and CXCR oy;N3  
>OBuHqC  
7.Lectin (or mitogen) k'xnl"q  
eN,s#/ip]  
8.Clusters of differentiation, CD) _C)u#]t  
?A8Uf=  
9.B7 family `Btdp:j8i  
o`DBzC  
10.Cytotoxic T lymphocyte, CTL) H2zd@l:R  
BO#fzq%  
11.IL-15 and IL-15 receptor (IL-15R) KJ.ra\ F  
SrN0f0  
12.MHC restriction XaR(q2s  
]zhFFq`  
13.Affinity-chromatography _U.8 \J2  
&dbX>u q  
14.Cyctosprin A, CsA V}'|a<8kVv  
hh|'Uq3  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) <*3wnpj_  
?$ Uk[  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© *[.+|v;A  
1mFc]1W  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 IE|x+RBD  
6:330"9  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ XFG]%y=/6  
w^A8ZT0^7  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ nUs)  
R+]Fh4t  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ~ W52Mbf  
K)_0ej~C  
ÃâÒßѧרҵ£º eq(|%]a=  
r1}7Q7-z  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ : b $ M  
:2 QA #  
Ïû»¯ÄÚ¿Æ£º j 9y,UT  
ZH0 ~:  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ nITr5$f  
+\"@2mOH{+  
ѪҺ²¡Ñ§×¨Òµ£º Z TjlGU `  
a9FlzR  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»